The University of Chicago Header Logo

Connection

Walter M. Stadler to Triazoles

This is a "connection" page, showing publications Walter M. Stadler has written about Triazoles.
Connection Strength

0.242
  1. Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901. J Clin Oncol. 2005 Jun 01; 23(16):3726-32.
    View in: PubMed
    Score: 0.242
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.